Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)

Condition:   Seasonal Allergic RhinitisInterventions:   Drug: Desloratadine 5 mg;   Drug: PlaceboSponsor:   Merck Sharp & Dohme Corp.Active, not recruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials